ClinicalTrials.gov
ClinicalTrials.gov Menu

ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir (ATAGLU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02102048
Recruitment Status : Unknown
Verified March 2014 by Giancarlo Ceccarelli, University of Roma La Sapienza.
Recruitment status was:  Active, not recruiting
First Posted : April 2, 2014
Last Update Posted : April 2, 2014
Sponsor:
Information provided by (Responsible Party):
Giancarlo Ceccarelli, University of Roma La Sapienza

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : March 2014
  Estimated Study Completion Date : July 2014